Physician profile
Amy Ash
NPI 1053928903
$1,084.92
in general payments reported to CMS, 2019-2025
13 companies · $743 in 2025
The $743 reported for 2025 was more than what 82% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.86 · 2022: $129 · 2023: $91.57 · 2024: $104 · 2025: $743.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $939.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $938.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Forte Bio-Pharma LLC | $318.46 | 2021-2025 | Prolate, Nalocet, Tanlor |
| Atland Pharmaceuticals, LLC | $255.88 | 2025 | Orphenadrine Citrate, Aspirin and Caffeine, Tolmetin Sodium |
| Zynex Medical, INC. | $156.09 | 2025 | Nexwave |
| Globus Medical, INC. | $72.10 | 2025 | Senza |
| Grt US Holding, INC. | $62.24 | 2022 | |
| Saluda Medical Americas, INC. | $41.95 | 2025 | Evoke |
| Hikma Pharmaceuticals USA | $40.58 | 2022 | |
| Merck Sharp & Dohme LLC | $37.00 | 2024-2025 | Bridion |
| Amgen INC. | $26.57 | 2022 | |
| Collegium Pharmaceutical, INC. | $22.04 | 2024 | Belbuca |
| Masimo Corporation | $19.17 | 2023 | Set and Rainbow Set |
| Tonix Medicines, INC. | $16.62 | 2025 | Tonmya |
| Curonix LLC | $16.22 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Ash listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.